Compositions comprising modified HIV envelopes
US11814413B2 · kind B2 · utility
0Cited by
1References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2018 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Mar 14, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to immunogens and methods for inducing immune responses, comprising methods for germline B cell stimulation and maturation by reverse engineering of HIV-1 envelopes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.